These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 20228877)
1. Chemical synthesis and proinflammatory responses of monophosphoryl lipid A adjuvant candidates. Maiti KK; Decastro M; El-Sayed AB; Foote MI; Wolfert MA; Boons GJ European J Org Chem; 2010 Jan; 2010(1):80-91. PubMed ID: 20228877 [TBL] [Abstract][Full Text] [Related]
2. Immuno-Stimulatory Activity of Escherichia coli Mutants Producing Kdo2-Monophosphoryl-Lipid A or Kdo2-Pentaacyl-Monophosphoryl-Lipid A. Wang B; Han Y; Li Y; Li Y; Wang X PLoS One; 2015; 10(12):e0144714. PubMed ID: 26710252 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of monophosphoryl lipid A using 2-naphtylmethyl ethers as permanent protecting groups. Verpalen ECJM; Brouwer AJ; Boons GJ Carbohydr Res; 2020 Dec; 498():108152. PubMed ID: 33032087 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of Salmonella minnesota Re595 lipopolysaccharide, lipid A and monophosphoryl lipid A on nitric oxide, TNF-alpha, and IL-6 induction from RAW 264.7 macrophages. Aybay C; Imir T FEMS Immunol Med Microbiol; 1998 Nov; 22(3):263-73. PubMed ID: 9848688 [TBL] [Abstract][Full Text] [Related]
5. Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results. Cluff CW Adv Exp Med Biol; 2010; 667():111-23. PubMed ID: 20665204 [TBL] [Abstract][Full Text] [Related]
7. Monophosphoryl lipid A induces protection against LPS in medullary thick ascending limb through a TLR4-TRIF-PI3K signaling pathway. Watts BA; George T; Sherwood ER; Good DW Am J Physiol Renal Physiol; 2017 Jul; 313(1):F103-F115. PubMed ID: 28356284 [TBL] [Abstract][Full Text] [Related]
8. Endothelial cell tolerance to lipopolysaccharide challenge is induced by monophosphoryl lipid A. Stark RJ; Choi H; Koch SR; Fensterheim BA; Lamb FS; Sherwood ER Clin Sci (Lond); 2016 Mar; 130(6):451-61. PubMed ID: 26669797 [TBL] [Abstract][Full Text] [Related]
9. Monophosphoryl lipid A directly regulates Th1 cytokine production in human CD4 Komai-Koma M; Ji Y; Cao H; Liu Z; McSharry C; Xu D Immunobiology; 2021 Sep; 226(5):152132. PubMed ID: 34478947 [TBL] [Abstract][Full Text] [Related]
10. Contribution of TLR4 and MyD88 for adjuvant monophosphoryl lipid A (MPLA) activity in a DNA prime-protein boost HIV-1 vaccine. Pouliot K; Buglione-Corbett R; Marty-Roix R; Montminy-Paquette S; West K; Wang S; Lu S; Lien E Vaccine; 2014 Sep; 32(39):5049-56. PubMed ID: 25045815 [TBL] [Abstract][Full Text] [Related]
11. Monophosphoryl lipid A-induced pro-inflammatory cytokine expression does not require CD14 in primary human dendritic cells. Kolanowski ST; Lissenberg-Thunnissen SN; Emal D; van Ham SM; Ten Brinke A Inflamm Res; 2016 Jun; 65(6):449-58. PubMed ID: 26994069 [TBL] [Abstract][Full Text] [Related]
12. Comparative Transcriptome Profiles of Human Blood in Response to the Toll-like Receptor 4 Ligands Lipopolysaccharide and Monophosphoryl Lipid A. Luan L; Patil NK; Guo Y; Hernandez A; Bohannon JK; Fensterheim BA; Wang J; Xu Y; Enkhbaatar P; Stark R; Sherwood ER Sci Rep; 2017 Jan; 7():40050. PubMed ID: 28053314 [TBL] [Abstract][Full Text] [Related]
13. Monophosphoryl lipid A inhibits the cytokine response of endothelial cells challenged with LPS. Stark R; Choi H; Koch S; Lamb F; Sherwood E Innate Immun; 2015 Aug; 21(6):565-74. PubMed ID: 25540284 [TBL] [Abstract][Full Text] [Related]
14. The immunobiology of toll-like receptor 4 agonists: from endotoxin tolerance to immunoadjuvants. Bohannon JK; Hernandez A; Enkhbaatar P; Adams WL; Sherwood ER Shock; 2013 Dec; 40(6):451-62. PubMed ID: 23989337 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant activity of naturally occurring monophosphoryl lipopolysaccharide preparations from mucosa-associated bacteria. Chilton PM; Hadel DM; To TT; Mitchell TC; Darveau RP Infect Immun; 2013 Sep; 81(9):3317-25. PubMed ID: 23798540 [TBL] [Abstract][Full Text] [Related]
17. Engineering Escherichia coli for constitutive production of monophosphoryl lipid A vaccine adjuvant. Jin H; Ji Y; An J; Ha DH; Lee YR; Kim HJ; Lee CG; Jeong W; Kwon IC; Yang EG; Kim KH; Lee C; Chung HS Biotechnol Bioeng; 2024 Mar; 121(3):1144-1162. PubMed ID: 38184812 [TBL] [Abstract][Full Text] [Related]
18. Monophosphoryl lipid A induces protection against LPS in medullary thick ascending limb through induction of Tollip and negative regulation of IRAK-1. Watts BA; Tamayo E; Sherwood ER; Good DW Am J Physiol Renal Physiol; 2019 Sep; 317(3):F705-F719. PubMed ID: 31241993 [TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathy. Venezia S; Refolo V; Polissidis A; Stefanis L; Wenning GK; Stefanova N Mol Neurodegener; 2017 Jul; 12(1):52. PubMed ID: 28676095 [TBL] [Abstract][Full Text] [Related]
20. Specific features of human monocytes activation by monophosphoryl lipid A. Chentouh R; Fitting C; Cavaillon JM Sci Rep; 2018 May; 8(1):7096. PubMed ID: 29728623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]